Agios Pharmaceuticals, Inc. (LON:0HB0)
London
· Delayed Price · Currency is GBP · Price in USD 28.26
+0.31 (1.09%)
At close: May 15, 2025
Agios Pharmaceuticals Revenue
Agios Pharmaceuticals had revenue of $8.73M USD in the quarter ending March 31, 2025, with 6.56% growth. This brings the company's revenue in the last twelve months to $37.04M, up 25.96% year-over-year. In the year 2024, Agios Pharmaceuticals had annual revenue of $36.50M with 36.07% growth.
Revenue (ttm)
$37.04M
Revenue Growth
+25.96%
P/S Ratio
42.99
Revenue / Employee
$75.89K
Employees
488
Market Cap
1.23B GBP
Revenue Chart
* This company reports financials in USD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 42.56B |
| GSK plc | 31.53B |
| Haleon | 11.23B |
| Smith & Nephew | 4.64B |
| ConvaTec Group | 1.83B |
| Hikma Pharmaceuticals | 2.50B |
| HUTCHMED (China) | 503.39M |
| Genus | 671.60M |
Agios Pharmaceuticals News
- 6 days ago - Agios to Present at the 2025 RBC Capital Markets Global Healthcare Conference on May 21, 2025 - GlobeNewsWire
- 13 days ago - Agios to Present at the BofA Securities 2025 Health Care Conference on May 14, 2025 - GlobeNewsWire
- 14 days ago - Agios Pharmaceuticals, Inc. 2025 Q1 - Results - Earnings Call Presentation - Seeking Alpha
- 14 days ago - Agios pharmaceuticals outlines key catalysts for PYRUKYND pipeline in 2025 - Seeking Alpha
- 14 days ago - Agios Pharmaceuticals, Inc. (AGIO) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 14 days ago - Agios Pharmaceuticals GAAP EPS of -$1.55, revenue of $8.7M - Seeking Alpha
- 14 days ago - Agios Reports First Quarter 2025 Financial Results and Recent Business Highlights - GlobeNewsWire
- 15 days ago - Earnings Scheduled For May 1, 2025 - Benzinga